Ischaemic heart disease

This resource will help you work towards the National Centre for Smoking Cessation and Training (NCSCT) certification by acquiring the knowledge, developing the skills and demonstrating the behaviours necessary to provide effective support for smoking cessation. You can view the web resources and relevant links required for this programme.

Learning Objectives:

• explain the harmful effects of smoking and the health benefits of stopping
• compare local and national smoking prevalence and patterns of smoking cessation across different demographics
• discuss the principles and effectiveness of behavioural support and pharmacological therapies to support smoking cessation
• assess a client’s commitment, readiness and ability to stop smoking and, where appropriate, assist a client to set a quit date
• apply evidence-based behavioural change techniques to tailor individual support for clients at different stages of a quit attempt
• apply appropriate behavioural support strategies to motivate a client to continue with a quit attempt
• demonstrate an effective approach to dealing with lapses
• improve the quality of stop smoking support provided, by offering constructive feedback to pharmacy team members
• construct an effective response to clients’ questions about stopping smoking and the various treatment options.

This e-learning programme provides an overview of the management of stable angina. It will equip learners with the knowledge and skills to offer a comprehensive medicines management service to people with this condition.

Please note: this e-learning programme has been developed and provided by the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD). Users should recognise that this programme will refer to Northern Ireland's policies and organisations. After ordering this programme, you will be redirected to their website where the resource is hosted. Please be aware that CPPE does not maintain control over the accuracy and currency of this programme.

Learning Objectives:

• describe the factors involved in the diagnosis of stable angina
• identify the risk factors associated with increased mortality in patients with stable angina
• adopt an evidence-based approach to the management of stable angina
• make recommendations for second-line treatment if first-line therapy is unsuitable or cannot be tolerated
• understand the role of novel medication for patients with stable angina.

The focus of this learning programme is to consider options for second-line angina treatment and how primary care teams can contribute to delivering a positive patient experience for people with angina.

Learning Objectives:

• discuss the evidence base underpinning second-line medicines for stable angina
• assess which second-line medicine is most appropriate for an individual
• outline the key points for medicines optimisation in stable angina
• be aware of resources, including those for patients, to support medicines optimisation in this clinical area
• develop an action plan to improve medicines optimisation and reduce hospital admissions.

The overall aim of this learning programme is to provide and signpost you to key learning to increase your confidence in providing effective NMS consultations for patients newly prescribed an antihypertensive medicine.

Learning Objectives:

• discuss the key issues in the drug management of hypertension
• find key resources to help you plan and complete NMS consultations for patients taking antihypertensives
• list the key counselling points for patients taking antihypertensives as a new medicine
• provide advice for patients presenting with questions and concerns at an NMS consultation.

http://antibioticguardian.com/

This e-learning programme provides a holistic overview of the pharmacological and non-pharmacological management of heart failure, including a presentation about considerations for end of life care. This programme will equip learners with the knowledge and skills to provide a comprehensive medicines management service to patients with this condition.

Please note: this e-learning programme has been developed and provided by the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD). Users should recognise that this programme will refer to Northern Ireland's policies and organisations. After ordering this programme, you will be redirected to their website where the resource is hosted. Please be aware that CPPE does not maintain control over the accuracy and currency of this programme.

Learning Objectives:

• identify the risk factors for developing chronic heart failure
• classify heart failure according to disease severity
• recognise the symptoms of disease progression
• describe best practice guidance in relation to both the pharmacological and non-pharmacological management of the condition
• provide advice to patients with heart failure on lifestyle changes that may alleviate symptoms
• list the palliative care needs of patients with end-stage heart failure
• identify your role in the management of this patient group.

The aim of this e-learning programme is to provide you with a better understanding of vascular risk and the NHS health check programme.

It looks at the health policy surrounding the NHS health check programme and how it is commissioned. This learning defines cardiovascular risk and looks at some of the different assessment tools available and how these are used to estimate an individual’s cardiovascular risk.

It looks at the importance of communication with patients about their modifiable risk factors. Information on how to perform the NHS health check has been included and how to embed clinical governance into your NHS health check service.

Learning Objectives:

• define the term cardiovascular risk and discuss which vascular diseases are included in the NHS health check programme
• describe how the NHS health check programme fits into current health policy, how it is commissioned and some of the practical aspects of providing a pharmacy-based service
• assess an individual’s risk of developing cardiovascular disease (CVD) using appropriate evidence-based tools
• explain management options for modifiable risk factors following an NHS health check
• manage patients identified as having low, medium or high risk
• identify situations where referral to another practitioner is appropriate following the NHS health check
• develop strategies for communicating with patients who are at risk of CVD.

This e-learning programme will help improve your knowledge about the prevalence of overweight and obesity, the structure of weight management services in England and the structure and requirements of a tier two commissioned lifestyle weight management service.

It provides you with practical advice on how you can support patients on their own weight loss journey, including how to initiate the difficult discussion around weight management.

Learning Objectives:

• outline the epidemiology of obesity
• use appropriate equipment and techniques to measure and categorise a person's degree of overweight or obesity
• describe the determinants and health risks of being overweight or obese and the benefits of maintaining a healthy weight
• assess a person's readiness to lose weight and willingness to modify behaviour to achieve and maintain an appropriate target weight
• describe a range of motivational and behavioural techniques to support weight management
• discuss the role of diet, physical activity, medicines and surgery in the management of weight and provide practical healthy lifestyle advice
• select the most appropriate intervention or referral pathway to other primary/secondary care specialist services where necessary, in line with local and national weight management strategies
• describe and implement a community pharmacy weight management service.

We’ve developed an online learning environment to promote and support work-based teaching and learning opportunities for the whole community pharmacy team. The learning platform is easily accessed at:theLearningpharmacy.com and has been developed for everyone in the community pharmacy. When you visit the site you can choose from a selection of topics or ‘pharmacy floors’ where you can select and work through practice-based, bite-sized learning challenges. Each challenge provides 10-15 minutes of quality learning and they’ve been developed to be fun and interactive.

QRISK Explaining annual updates

NICE CG126 Stable angina: management

NICE CG127 Hypertension in adults: diagnosis and management

NICE CG172 Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease

NICE CG181 Cardiovascular disease: risk assessment and reduction, including lipid modification